Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, et al. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide 2013. http://globocan.iarc.fr, accessed on 30/01/2015.
El-Serag HB. Hepatocellular carcinoma. N Engl J Med. 2011;365:1118–27.
Article
CAS
PubMed
Google Scholar
Chen Y, Wang X, Wang J, Yan Z, Luo J. Excess body weight and the risk of primary liver cancer: an updated meta-analysis of prospective studies. Eur J Cancer. 2012;48:2137–45.
Article
PubMed
Google Scholar
Chuang SC, La Vecchia C, Boffetta P. Liver cancer: descriptive epidemiology and risk factors other than HBV and HCV infection. Cancer Lett. 2009;286:9–14.
Article
CAS
PubMed
Google Scholar
Wang P, Kang D, Cao W, Wang Y, Liu Z. Diabetes mellitus and risk of hepatocellular carcinoma: a systematic review and meta-analysis. Diabetes Metab Res Rev. 2012;28:109–22.
Article
PubMed
Google Scholar
Llovet JM, Burroughs A, Bruix J. Hepatocellular carcinoma. Lancet. 2003;362:1907–17.
Article
PubMed
Google Scholar
Nicholson JK, Lindon JC, Holmes E. ‘Metabonomics’: understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data. Xenobiotica. 1999;29:1181–9.
Article
CAS
PubMed
Google Scholar
Nicholson JK, Holmes E, Kinross JM, Darzi AW, Takats Z, Lindon JC. Metabolic phenotyping in clinical and surgical environments. Nature. 2012;491:384–92.
Article
CAS
PubMed
Google Scholar
Floegel A, Stefan N, Yu Z, Muhlenbruch K, Drogan D, Joost HG, et al. Identification of serum metabolites associated with risk of type 2 diabetes using a targeted metabolomic approach. Diabetes. 2013;62:639–48.
Article
CAS
PubMed
PubMed Central
Google Scholar
Griffin JL, Atherton H, Shockor J, Atzori L. Metabolomics as a tool for cardiac research. Nat Rev Cardiol. 2011;8:630–43.
Article
CAS
PubMed
Google Scholar
Griffin JL, Shockcor JP. Metabolic profiles of cancer cells. Nat Rev Cancer. 2004;4:551–61.
Article
CAS
PubMed
Google Scholar
Mayers JR, Wu C, Clish CB, Kraft P, Torrence ME, Fiske BP, et al. Elevation of circulating branched-chain amino acids is an early event in human pancreatic adenocarcinoma development. Nat Med. 2014;20:1193–8.
Article
CAS
PubMed
PubMed Central
Google Scholar
Shah SH, Sun JL, Stevens RD, Bain JR, Muehlbauer MJ, Pieper KS, et al. Baseline metabolomic profiles predict cardiovascular events in patients at risk for coronary artery disease. Am Heart J. 2012;163:844–50.
Article
CAS
PubMed
Google Scholar
Spratlin JL, Serkova NJ, Eckhardt SG. Clinical applications of metabolomics in oncology: a review. Clin Cancer Res. 2009;15:431–40.
Article
CAS
PubMed
PubMed Central
Google Scholar
Wang TJ, Larson MG, Vasan RS, Cheng S, Rhee EP, McCabe E, et al. Metabolite profiles and the risk of developing diabetes. Nat Med. 2011;17:448–53.
Article
PubMed
PubMed Central
Google Scholar
Beyoglu D, Imbeaud S, Maurhofer O, Bioulac-Sage P, Zucman-Rossi J, Dufour JF, et al. Tissue metabolomics of hepatocellular carcinoma: tumor energy metabolism and the role of transcriptomic classification. Hepatology. 2013;58:229–38.
Article
CAS
PubMed
PubMed Central
Google Scholar
Bowers J, Hughes E, Skill N, Maluccio M, Raftery D. Detection of hepatocellular carcinoma in hepatitis C patients: biomarker discovery by LC-MS. J Chromatogr B. 2014;966:154–62.
Article
CAS
Google Scholar
Chen J, Wang WZ, Lv S, Yin PY, Zhao XJ, Lu X, et al. Metabonomics study of liver cancer based on ultra performance liquid chromatography coupled to mass spectrometry with HILIC and RPLC separations. Anal Chim Acta. 2009;650:3–9.
Article
CAS
PubMed
Google Scholar
da Costa AN, Pontoizeau C, Plymoth A, Santos-Silva D, Mendy M, Sangrajrang S, et al. A multi-marker approach for early detection of HBV-related hepatocellular carcinoma in areas of high incidence. Eur J Cancer. 2012;48:S169–70.
Article
Google Scholar
Gao HC, Lu Q, Liu X, Cong H, Zhao LC, Wang HM, et al. Application of H-1 NMR-based metabonomics in the study of metabolic profiling of human hepatocellular carcinoma and liver cirrhosis. Cancer Sci. 2009;100:782–5.
Article
CAS
PubMed
Google Scholar
Huang Q, Tan YX, Yin PY, Ye GZ, Gao P, Lu X, et al. Metabolic characterization of hepatocellular carcinoma using nontargeted tissue metabolomics. Cancer Res. 2013;73:4992–5002.
Article
CAS
PubMed
Google Scholar
Liu SY, Zhang RL, Kang H, Fan ZJ, Du Z. Human liver tissue metabolic profiling research on hepatitis B virus-related hepatocellular carcinoma. World J Gastroenterol. 2013;19:3423–32.
Article
CAS
PubMed
PubMed Central
Google Scholar
Liu Y, Hong Z, Tan G, Dong X, Yang G, Zhao L, et al. NMR and LC/MS-based global metabolomics to identify serum biomarkers differentiating hepatocellular carcinoma from liver cirrhosis. Int J Cancer. 2014;135:658–68.
Article
CAS
PubMed
Google Scholar
Nahon P, Amathieu R, Triba MN, Bouchemal N, Nault JC, Ziol M, et al. Identification of serum proton NMR metabolomic fingerprints associated with hepatocellular carcinoma in patients with alcoholic cirrhosis. Clin Cancer Res. 2012;18:6714–22.
Article
CAS
PubMed
Google Scholar
Patterson AD, Maurhofer O, Beyoglu D, Lanz C, Krausz KW, Pabst T, et al. Aberrant lipid metabolism in hepatocellular carcinoma revealed by plasma metabolomics and lipid profiling. Cancer Res. 2011;71:6590–600.
Article
CAS
PubMed
PubMed Central
Google Scholar
Ressom HW, Xiao JF, Tuli L, Varghese RS, Zhou B, Tsai TH, et al. Utilization of metabolomics to identify serum biomarkers for hepatocellular carcinoma in patients with liver cirrhosis. Anal Chim Acta. 2012;743:90–100.
Article
CAS
PubMed
Google Scholar
Soga T, Sugimoto M, Honma M, Mori M, Igarashi K, Kashikura K, et al. Serum metabolomics reveals gamma-glutamyl dipeptides as biomarkers for discrimination among different forms of liver disease. J Hepatology. 2011;55:896–905.
Article
CAS
Google Scholar
Tan YX, Yin PY, Tang L, Xing WB, Huang Q, Cao D, et al. Metabolomics study of stepwise hepatocarcinogenesis from the model rats to patients: potential biomarkers effective for small hepatocellular carcinoma diagnosis. Mol Cell Proteomics. 2012;11:M111.010694.
Article
PubMed
Google Scholar
Wu H, Xue RY, Dong L, Liu TT, Deng CH, Zeng HZ, et al. Metabolomic profiling of human urine in hepatocellular carcinoma patients using gas chromatography/mass spectrometry. Anal Chim Acta. 2009;648:98–104.
Article
CAS
PubMed
Google Scholar
Xiao JF, Varghese RS, Zhou B, Ranjbar MRN, Zhao Y, Tsai TH, et al. LC-MS based serum metabolomics for identification of hepatocellular carcinoma biomarkers in Egyptian cohort. J Proteome Res. 2012;11:5914–23.
CAS
PubMed
PubMed Central
Google Scholar
Zhou LN, Wang QC, Yin PY, Xing WB, Wu ZM, Chen SL, et al. Serum metabolomics reveals the deregulation of fatty acids metabolism in hepatocellular carcinoma and chronic liver diseases. Anal Bioanal Chem. 2012;403:203–13.
Article
CAS
PubMed
Google Scholar
Fedirko V, Duarte-Salles T, Bamia C, Trichopoulou A, Aleksandrova K, Trichopoulos D, et al. Prediagnostic circulating vitamin D levels and risk of hepatocellular carcinoma in European populations: a nested case-control study. Hepatology. 2014;60:1222–30.
Article
CAS
PubMed
Google Scholar
Lai GY, Weinstein SJ, Albanes D, Taylor PR, Virtamo J, McGlynn KA, et al. Association of serum alpha-tocopherol, beta-carotene, and retinol with liver cancer incidence and chronic liver disease mortality. Br J Cancer. 2014;111:2163–71.
Article
CAS
PubMed
PubMed Central
Google Scholar
Lukanova A, Becker S, Husing A, Schock H, Fedirko V, Trepo E, et al. Prediagnostic plasma testosterone, sex hormone-binding globulin, IGF-I and hepatocellular carcinoma: etiological factors or risk markers? Int J Cancer. 2013;134:164–73.
Article
CAS
PubMed
Google Scholar
Riboli E, Hunt KJ, Slimani N, Ferrari P, Norat T, Fahey M, et al. European prospective investigation into cancer and nutrition (EPIC): study populations and data collection. Public Health Nutr. 2002;5:1113–24.
Article
CAS
PubMed
Google Scholar
Trichopoulos D, Bamia C, Lagiou P, Fedirko V, Trepo E, Jenab M, et al. Hepatocellular carcinoma risk factors and disease burden in a European cohort: a nested case-control study. J Natl Cancer Inst. 2011;103:1686–95.
Article
PubMed
PubMed Central
Google Scholar
Fedirko V, Trichopolou A, Bamia C, Duarte-Salles T, Trepo E, Aleksandrova K, et al. Consumption of fish and meats and risk of hepatocellular carcinoma: the European Prospective Investigation into Cancer and Nutrition (EPIC). Ann Oncol. 2013;24:2166–73.
Article
CAS
PubMed
PubMed Central
Google Scholar
Beckonert O, Keun HC, Ebbels TMD, Bundy JG, Holmes E, Lindon JC, et al. Metabolic profiling, metabolomic and metabonomic procedures for NMR spectroscopy of urine, plasma, serum and tissue extracts. Nat Protoc. 2007;2:2692–703.
Article
CAS
PubMed
Google Scholar
Wishart DS, Knox C, Guo AC, Eisner R, Young N, Gautam B, et al. HMDB: a knowledgebase for the human metabolome. Nucleic Acids Res. 2009;37:D603–10.
Article
CAS
PubMed
Google Scholar
Cui Q, Lewis IA, Hegeman AD, Anderson ME, Li J, Schulte CF, et al. Metabolite identification via the Madison Metabolomics Consortium Database. Nat Biotechnol. 2008;26:162–4.
Article
CAS
PubMed
Google Scholar
Trygg J, Wold S. Orthogonal projections to latent structures (O-PLS). J Chemometrics. 2002;16:119–28.
Article
CAS
Google Scholar
Good PI. Permutation tests: a practical guide to resampling methods for testing hypotheses. New York: Spinger-Verlag; 2000.
Book
Google Scholar
Blaise BJ, Shintu L, Elena B, Emsley L, Dumas ME, Toulhoat P. Statistical recoupling prior to significance testing in nuclear magnetic resonance based metabonomics. Anal Chem. 2009;81:6242–51.
Article
CAS
PubMed
Google Scholar
Benjamini Y, Hochberg Y. Controlling the false discovery rate – a practical and powerful approach to multiple testing. J R Stat Soc Ser B. 1995;57:289–300.
Google Scholar
Fages A, Ferrari P, Monni S, Dossus L, Floegel A, Mode N, et al. Investigating sources of variability in metabolomic data in the EPIC study: the principal component partial R-square (PC-PR2) method. Metabolomics. 2014;10:1074–83.
Article
CAS
Google Scholar
R Core Team (2013). R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. URL http://www.R-project.org/.
Ghoshal AK, Farber E. Choline deficiency, lipotrope deficiency and the development of liver disease including liver cancer: a new perspective. Lab Invest. 1993;68:255–60.
CAS
PubMed
Google Scholar
Haussinger D. Regulation of hepatic ammonia metabolism: the intercellular glutamine cycle. Adv Enzyme Regul. 1986;25:159–80.
Article
CAS
PubMed
Google Scholar
Pogribny IP, James SJ, Beland FA. Molecular alterations in hepatocarcinogenesis induced by dietary methyl deficiency. Mol Nutr Food Res. 2012;56:116–25.
Article
CAS
PubMed
Google Scholar
Watford M. Glutamine and glutamate metabolism across the liver sinusoid. J Nutr. 2000;130:983S–7.
CAS
PubMed
Google Scholar
Psychogios N, Hau DD, Peng J, Guo AC, Mandal R, Bouatra S, et al. The human serum metabolome. PLoS One. 2011;6:e16957.
Article
CAS
PubMed
PubMed Central
Google Scholar
Zar T, Graeber C, Perazella MA. Recognition, treatment, and prevention of propylene glycol toxicity. Semin Dial. 2007;20:217–9.
Article
PubMed
Google Scholar
Beyofülu D, Idle JR. The metabolomic window into hepatobiliary disease. J Hepatol. 2013;59:842–58.
Article
Google Scholar
Barr J, Caballeria J, Martinez-Arranz I, Dominguez-Diez A, Alonso C, Muntane J, et al. Obesity-dependent metabolic signatures associated with nonalcoholic fatty liver disease progression. J Proteome Res. 2012;11:2521–32.
Article
CAS
PubMed
PubMed Central
Google Scholar
Barr J, Vazquez-Chantada M, Alonso C, Perez-Cormenzana M, Mayo R, Galan A, et al. Liquid chromatography-mass spectrometry-based parallel metabolic profiling of human and mouse model serum reveals putative biomarkers associated with the progression of nonalcoholic fatty liver disease. J Proteome Res. 2010;9:4501–12.
Article
CAS
PubMed
PubMed Central
Google Scholar
Tanaka N, Matsubara T, Krausz KW, Patterson AD, Gonzalez FJ. Disruption of phospholipid and bile acid homeostasis in mice with nonalcoholic steatohepatitis. Hepatology. 2012;56:118–29.
Article
CAS
PubMed
Google Scholar
Qi SW, Tu ZG, Peng WJ, Wang LX, Ou-Yang X, Cai AJ, et al. (1)H NMR-based serum metabolic profiling in compensated and decompensated cirrhosis. World J Gastroenterol. 2012;18:285–90.
Article
PubMed
PubMed Central
Google Scholar
Lin X, Zhang Y, Ye G, Li X, Yin P, Ruan Q, et al. Classification and differential metabolite discovery of liver diseases based on plasma metabolic profiling and support vector machines. J Sep Sci. 2011;34:3029–36.
Article
CAS
PubMed
Google Scholar